Durable Remissions And Increased Overall Survival In Aml Patients Deemed Unfit For Standard Intensive Chemotherapy Achieved With High-Dose Bst-236 (Aspacytarabine) Induction And Consolidation

BLOOD(2020)

引用 0|浏览31
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要